|
|
Article: PharMerica Reports Results for the Fourth Quarter 2008 and for the Year Ended December 31, 2008 and Provides 2009 Earnings Guidance.
- Article from:
- Biotech Week
- Article date:
- February 18, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PharMerica Corporation (NYSE: PMC): Revenues for 2008 were $1,947 Million Net income for 2008 was $5.0 Million, or $0.17 Diluted Earnings Per Share Cash Flow Provided by Operating Activities for 2008 was Approximately $66 Million Results include Intangible Impairment Charges of $14.8 Million Pre-Tax, or $0.30 Diluted Effect on Earnings Per Share Integration, Merger Related Costs and Other Charges were $26.7 Million, or $0.53 Diluted Effect on Earnings Per Share Adjusted EBITDA was $92.5 Million for 2008 PharMerica Corporation (NYSE: PMC), a national provider of institutional pharmacy and hospital pharmacy management services, reported the results of its fourth quarter and ...
Related newspaper, magazine, and journal articles:
|
|
Article: Lamar Advertising Company Announces Fourth Quarter ...
Business Wire;
February 12, 2003 ;
700+ words
... ... operating results for the fourth quarter and the year ended December 31, 2002. Fourth Quarter Results Lamar reported ... respectively as compared to the fourth quarter of 2001. The term ... 7 million for the year ended 2002 versus $729 ...
|
|